|Bid||286.08 x 800|
|Ask||293.94 x 1300|
|Day's range||291.04 - 295.16|
|52-week range||191.74 - 296.29|
|Beta (5Y monthly)||0.71|
|PE ratio (TTM)||17.54|
|Earnings date||03 Nov 2022|
|Forward dividend & yield||4.48 (1.53%)|
|Ex-dividend date||06 Sept 2022|
|1y target est||314.22|
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Cigna (CI) expects to bump up its Pathwell suite's availability throughout the next year.
Cigna (CI) is aided by powerful segmental performances, solid demand for its Medicare plans, divestitures and solid cash-generating abilities.